http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201016647-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7f120efe096284c7389702c969cf3d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-88
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-88
filingDate 2009-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e605be51cfe35180b6011c012810c19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b54b911a45952acf86ec9208edc8255
publicationDate 2010-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201016647-A
titleOfInvention Asymmetric azine compound and method for producing the same
abstract Disclosed are a novel asymmetric azine compound (I), and a method for producing an asymmetric azine compound (I) which is characterized in that an aldehyde compound (III) and hydrazine are reacted in an alcohol solvent at a molar ratio (aldehyde compound (III)):(hydrazine) of from 2:1 to 1:2, thereby obtaining a reaction liquid containing a hydrazone compound (IV), and then an aldehyde compound (V) is added for a reaction into the thus-obtained reaction liquid at a molar ratio (aldehyde compound (V)):(hydrazone compound (IV)) of from 2:1 to 1:2. The method can commercially advantageously produce an asymmetric azine compound having a polar group such as a hydroxy group or a carboxyl group in each molecule. The novel asymmetric azine compound can be obtained by this production method. (In the formulae, R1 and R2 each represents a hydroxy group or a carboxyl group; X1-X8 each represents a hydrogen atom, -C(=O)-OR3 or the like; and R3 represents an alkyl group having 1-10 carbon atoms, or the like.)
priorityDate 2008-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453793281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21901440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426210633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14363598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456373579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12313776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410534197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421337469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 47.